PhD positions available within our group: 7th January 2019 deadline
A number of PhD positions are available within the group.
Funding will be allocated to successful applicants rather, than project. Successful applicant will receive tuition fees(UK/EU) paid and a stipend (for UK residents only).
Closing date for all applications is 7th January 2019 with interviews being scheduled for February 2019.
Dr Garry Laverty (First supervisor) and Professor Karl Malcolm: Peptide hydrogels as a long-acting multipurpose drug delivery platform for combined contraception and HIV prevention
Dr Irina Tikhonova and Dr Garry Laverty (second supervisor) – Rational design of novel peptide hydrogels for drug delivery
More details can be found at the School of Pharmacy link below:
Feel free to contact us if any questions about the projects or our work.
Group receive major funding from EPSRC to develop peptide-like hydrogels for combined HIV-contraceptive therapy
We are excited to announce support from the Engineering and Physical Sciences Research Council (EPSRC) to develop of peptide-like hydrogels for use as a long-acting injectable delivery platform for combined HIV-contraceptive drug delivery. Total support (£766,542) will allow further development of our peptide-mimetic platforms in a key healthcare area in collaboration with our co-investigators at […]
New website launch!!
Welcome to our new and improved website! We hope this provides an accessible means to which we can communicate our research to a wider audience. Please check back regularly for important updates from our group. We’d like to thank Artisan Web Design Belfast for their help in constructing the site and the Royal Society for providing […]